 |
|
Relationship between nonalcoholic fatty liver disease and hyperandrogenemia in adolescents with polycystic ovary syndrome
Ozlem Kara, Hanife Aysegul Arsoy, Murat Keskin
Clin Exp Pediatr. 2023;66(9):395-402. Published online 2023 Jun 14 DOI: https://doi.org/10.3345/cep.2023.00353
|
|
Citations to this article as recorded by
 Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort
Donna Vine, Mahua Ghosh, Ting Wang, Jeffrey Bakal
CJC Open.2024; 6(2): 314. CrossRef Impact of Comorbid Polycystic Ovary Syndrome on Clinical and Laboratory Parameters in Female Adolescents with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Cross-Sectional Study
Murat Keskin, Hanife Aysegul Arsoy, Ozlem Kara, Emre Sarandol, Nizameddin Koca, Yusuf Yilmaz
Journal of Clinical Medicine.2024; 13(19): 5885. CrossRef Treatment and complications of PCOS in adolescents - what’s new in 2023?
Karolina Jakubowska-Kowal, Karolina Skrzyńska, Aneta Gawlik-Starzyk
Frontiers in Endocrinology.2024;[Epub] CrossRef Visceral adipose tissue, epicardial fat, and hepatic steatosis in polycystic ovary syndrome: a study of ectopic fat stores and metabolic dysfunction
Rebeca Bandeira de Melo Cavalcante, Lenora Maria Camarate Silveira Mart Leão, Ana Beatriz Winter Tavares, Karynne Grutter Lopes, Carlos Terra, Angelo Antunes Salgado, Luiz Guilherme Kraemer-Aguiar
Endocrine.2024; 87(2): 866. CrossRef
|